Finance

Lists
Why is ALTHE up 4.81%?
Dive Deeper
ALTHE:EPA
Theraclion SA
€0.72
+4.81%
(+0.033) 1D
Nov 5, 5:35:20 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALTHE...
Open
€0.69
High
€0.74
Low
€0.69
Mkt. cap
70.97M
Avg. vol.
53.98K
Volume
68.43K
52-wk high
€0.93
52-wk low
€0.40
EPS
-€0.10
Shares outstanding
73.81M
No. of employees
34
Open
€0.69
High
€0.74
Low
€0.69
Mkt. cap
70.97M
Avg. vol.
53.98K
Volume
68.43K
52-wk high
€0.93
52-wk low
€0.40
EPS
-€0.10
Shares outstanding
73.81M
No. of employees
34
News stories
From web sources and news partners
About Theraclion SA
CEODavid Auregan
Employees34
Founded2004
Headquarters-
SectorMedical device
Industry-
Websitetheraclion.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-92.50K
-92.50K
331.00K
331.00K
Cost of goods sold
897.00K
897.00K
566.00K
566.00K
Cost of revenue
897.00K
897.00K
566.00K
566.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
942.50K
942.50K
1.92M
1.92M
Operating expense
1.48M
1.48M
1.72M
1.72M
Total operating expenses
2.37M
2.37M
2.29M
2.29M
Operating income
-2.46M
-2.46M
-1.96M
-1.96M
Other non operating income
500.00
500.00
500.00
500.00
EBT including unusual items
-1.76M
-1.76M
-2.03M
-2.03M
EBT excluding unusual items
-2.46M
-2.46M
-2.03M
-2.03M
Income tax expense
-181.00K
-181.00K
-225.00K
-225.00K
Effective tax rate
10.30%
10.30%
11.09%
11.09%
Other operating expenses
420.50K
420.50K
-192.50K
-192.50K
Net income
-1.58M
-1.58M
-1.80M
-1.80M
Net profit margin
1,703.78%
1,703.78%
-544.71%
-544.71%
Earnings per share
-
-
-
-
Interest and investment income
9.50K
9.50K
-
-
Interest expense
-9.50K
-9.50K
-70.50K
-70.50K
Net interest expenses
-
-
-70.50K
-70.50K
Depreciation and amortization charges
112.50K
112.50K
-
-
EBITDA
-2.34M
-2.37M
-1.86M
-1.86M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps